Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 11, Issue 10, pp. 2183-2192
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 31, 2012
- Revision received July 20, 2012
- Accepted August 6, 2012
- Published first August 13, 2012.
Article Versions
- Previous version (August 13, 2012 - 13:36).
- Previous version (October 2, 2012 - 14:34).
- You are viewing the most recent version of this article.
Copyright & Usage
©2012 American Association for Cancer Research.
Author Information
- Sagar Agarwal1,6,
- Rajendar K. Mittapalli1,6,
- David M. Zellmer2,
- Jose L. Gallardo2,
- Randy Donelson2,
- Charlie Seiler2,
- Stacy A. Decker3,
- Karen S. SantaCruz4,
- Jenny L. Pokorny7,
- Jann N. Sarkaria7,
- William F. Elmquist1,6, and
- John R. Ohlfest2,5,6
- Authors' Affiliations: Departments of 1Pharmaceutics, 2Pediatrics, 3Neuroscience, 4Laboratory Medicine and Pathology, and 5Neurosurgery; 6Brain Barriers Research Center, University of Minnesota, Minneapolis; and 7Department of Radiation Oncology, Mayo Clinic, Rochester, Minneapolis
- Corresponding Author:
John Ohlfest, Department of Pediatrics, University of Minnesota, 420 Delaware St. SE, MMC 366, Minneapolis, MN 55455. Phone: 612-626-2491; Fax: 612-626-2490; E-mail: ohlfe001{at}umn.edu
October 2012
Volume 11, Issue 10
Volume 11, Issue 10
Active Efflux of Dasatinib from the Brain Limits Efficacy against Murine Glioblastoma: Broad Implications for the Clinical Use of Molecularly Targeted Agents
Jump to section
Advertisement